Scienture (SCNX) Stock Price, News & Analysis

Company Overview

TRxADE HEALTH, Inc. operates as health services IT company. It offers an online web-based buying and selling platform for licensed pharmaceutical wholesalers to sell brand, generic, and non-drug products and services to government organizations, hospitals, clinics and independent pharmacies. TRxADE HEALTH, Inc. is headquartered in Tampa, Florida.

Key Stats

• Today's Range: $8.37 to $8.37
• 50-Day Range: N/A
• 52-Week Range: $3.69 to $44.56
• Volume: 428 shs
• Average Volume: 169,921 shs
• Market Capitalization: $71.81 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SCNX Stock Analysis - Frequently Asked Questions

How have SCNX shares performed this year?

Scienture's stock was trading at $7.46 at the beginning of 2024. Since then, SCNX stock has increased by 12.2% and is now trading at $8.37.
View the best growth stocks for 2024 here.

How were Scienture's earnings last quarter?

Scienture Holdings, Inc. (NASDAQ:SCNX) issued its quarterly earnings data on Wednesday, November, 6th. The company reported ($1.34) EPS for the quarter. The business had revenue of $0.07 million for the quarter.

How do I buy shares of Scienture?

Shares of SCNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Scienture own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Scienture investors own include Cogent Communications (CCOI), Cavco Industries (CVCO), Liberty Broadband (LBRDK), Liberty Global (LBTYB), PayPal (PYPL), Roku (ROKU) and Arch Capital Group (ACGL).

Company Calendar

• Last Earnings: 11/06/2024
• Today: 11/21/2024
• Fiscal Year End: 12/31/2024
• Next Earnings (Estimated): 4/28/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:SCNX
• CUSIP: N/A
• CIK: 1382574
• Web: www.trxadehealth.com
• Phone: (800) 261-0281
• Fax: 800-265-6932
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-17,840,000.00
• Net Margins: N/A
• Pretax Margin: -305.64%
• Return on Equity: -77.60%
• Return on Assets: -62.29%

Debt

• Debt-to-Equity Ratio: 0.03
• Current Ratio: 1.34
• Quick Ratio: 1.34

Sales & Book Value

• Annual Sales: $8.27 million
• Price / Sales: 8.68
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $9.93 per share
• Price / Book: 0.84

Miscellaneous

• Outstanding Shares: 8,580,000
• Free Float: 6,081,000
• Market Cap: $71.81 million
• Optionable: N/A
• Beta: 2.31